Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study
Research Article
[키워드] 30-Day mortality
95% CI
acute respiratory syndrome
Admission
Adverse
adverse outcome
age
analyses
anti-inflammatory drug
association
cohort study
Comorbidities
concern
conducted
coronavirus
coronavirus disease
Course
COVID-19
COVID-19 patients
defined
died
drugs
early phase
eligible
European
female
fevers
for inclusion
groups
Health
Hospitalization
Hospitalized
ICU
ICU admission
individual
Infection
intensive care
limitation
mechanical ventilation
median age
Mortality
non-steroidal anti-inflammatory drug
NSAID
NSAIDS
outcome
Pain
pandemic
Patient
PCR-positive individual
population-based cohort
positive
raised
reduce
renal replacement therapy
researcher
residual confounding
risk
risk of COVID-19
risk ratio
RRs
SARS-CoV-2
SARS-COV-2 infection
secondary
selected
severe coronavirus disease
severe COVID-19
Sex
Side effects
study cohort
Symptom
tested
the SARS-CoV-2
treat
Treatment
union
[DOI] 10.1371/journal.pmed.1003308 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.1003308 PMC 바로가기 [Article Type] Research Article